Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) EBIT (2024 - 2025)

Profound Medical has reported EBIT over the past 2 years, most recently at $27.5 million for Q4 2025.

  • Quarterly results put EBIT at $27.5 million for Q4 2025, up 429.98% from a year ago — trailing twelve months through Dec 2025 was -$6.3 million (up 80.8% YoY), and the annual figure for FY2025 was -$6.3 million, up 80.8%.
  • EBIT for Q4 2025 was $27.5 million at Profound Medical, up from -$8.9 million in the prior quarter.
  • Over the last five years, EBIT for PROF hit a ceiling of $27.5 million in Q4 2025 and a floor of -$13.8 million in Q2 2025.